Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Dr August Wolff GmbH & Co. Kg Arzneimittel has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, LEESER, ERICH A, and is located in 1 distinct art unit. This structure indicates a singular and focused prosecution path for the company. The presence of 1 distinct art unit means that the prosecution is confined to a single specialized group within the patent office.
LEESER, ERICH A is the busiest examiner, currently managing 1 pending office action. This 1 action is the only one active out of the 1 pending office actions in the entire portfolio. Since there is only 1 distinct examiner, LEESER, ERICH A is the sole point of contact for the company's current Biotechnology & Pharmaceuticals filings. Practitioners can dedicate their resources to the 1 pending office action and the specific requirements of LEESER, ERICH A. This 1 pending office action represents the full scope of the company's current active workload.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEESER, ERICH A | 1 | 81.8% | +13.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18576983 | USE OF LACTIC ACID IN POSTMENOPAUSAL WOMEN | LEESER, ERICH A | 53d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18576983 | USE OF LACTIC ACID IN POSTMENOPAUSAL WOMEN | LEESER, ERICH A | 53d |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18576983 | USE OF LACTIC ACID IN POSTMENOPAUSAL WOMEN | LEESER, ERICH A | 1622 | §103 | Non-Final OA | 53d | Pending | Feb 09, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial